Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1969-2-4
|
| pubmed:abstractText |
The Central Veterinary Laboratory, Weybridge, England, was requested by the WHO Expert Committee on Biological Standardization to obtain suitable material for an international reference preparation of anti-Newcastle-disease serum for standardizing the haemagglutination-inhibition test for Newcastle disease and to arrange a collaborative assay. Ten laboratories in 10 countries assayed a batch of immune chicken serum against 2 test preparations. On the basis of the results obtained, the material has been established as the International Reference Preparation of Anti-Newcastle-Disease Serum and the International Unit of Anti-Newcastle-Disease Serum has been defined as the activity contained in 0.1734 mg of the International Reference Preparation of Anti-Newcastle-Disease Serum.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0042-9686
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
38
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
925-34
|
| pubmed:dateRevised |
2010-10-26
|
| pubmed:meshHeading | |
| pubmed:year |
1968
|
| pubmed:articleTitle |
International reference preparation of anti-Newcastle-disease serum.
|
| pubmed:publicationType |
Journal Article
|